论文部分内容阅读
中新网2月11日电据外媒报道,当地时间10日,美国犹他大学的研究人员表示,一种药效14小时的实验性药物“聪明胰岛素”在老鼠身上展现成效,2年内可望在第一型糖尿病患者身上进行测试。这篇发表于美国《国家科学院学报》的研究指出,由犹他大学生化学家研发的Ins-PBA-F,在血糖升高时能自我启动。对第一型糖尿病鼠进行的测试显示,给予老鼠相当于一餐摄取的糖后,注射一剂Ins-PBA-F,能不断且自动降血糖。
BEIJING, Feb. 11, according to foreign media reports, local time on the 10th, University of Utah researchers said a 14-hour experimental drug efficacy of “smart insulin” in rats show success, within 2 years It is expected to be tested on type 1 diabetics. The study, published in the Proceedings of the National Academy of Sciences in the United States, points out that Ins-PBA-F, developed by Utah University chemists, self-starts when blood sugar is elevated. Tests conducted on Type 1 diabetic mice showed that administering Ins-PBA-F, an insulin equivalent to a single meal of mice, consistently and automatically lowers blood sugar.